USNA
USANA Health Sciences Inc
14.70$
-1.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.3% | -0.6% | +0.3% | +6.3% | +11.5% | -0.2% | -1.6% | -1.1% | +2.2% | -0.5% | -4.8% | |
| – | +7.0% | +0.8% | -0.5% | +7.7% | -38.1% | +0.8% | -6.9% | +0.8% | +9.2% | +2.0% | -4.5% | |
| – | +7.6% | -0.6% | +1.2% | +9.8% | -50.2% | -1.2% | -15.7% | -4.0% | +9.0% | +2.8% | +3.6% | |
| – | +7.6% | -0.6% | +1.2% | +9.8% | -50.2% | -1.2% | -15.7% | -4.0% | +9.0% | +2.8% | +3.6% | |
| – | +720,099,900.0% | -100.0% | – | – | – | – | – | – | – | +6.1% | -65.4% | |
| – | +2.3% | -1.0% | +1.6% | +3.5% | +9.0% | +5.5% | +13.2% | +9.0% | +13.0% | -6.1% | -10.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.8% | -1.2% | -0.4% | +2.1% | +738.4% | +0.0% | +0.0% | +0.0% | -4.4% | +0.1% | -21.0% | |
| – | +1.6% | -2.7% | -1.6% | +2.1% | +419.3% | -3.1% | -3.0% | -3.2% | -3.6% | -3.2% | -3.3% | |
| – | +3.7% | -4.6% | -7.8% | +15.9% | +17.1% | +0.5% | -8.5% | -2.6% | +8.0% | -8.0% | -8.3% | |
| – | +5.6% | -5.2% | -7.8% | +10.5% | +21.6% | -1.6% | -11.5% | -2.4% | +8.3% | -8.8% | -9.9% | |
| – | – | -83.6% | – | – | – | -20.7% | – | – | – | +0.0% | – | |
| – | +8.0% | -17.9% | -19.6% | +5.9% | +70.2% | +16.6% | +28.1% | -4.5% | +1.0% | -6.0% | -4.9% | |
| – | +5.7% | +0.6% | +2.4% | +4.1% | -0.2% | -0.4% | +0.2% | -0.6% | +1.0% | +2.0% | -3.2% | |
| – | +3.9% | +1.8% | +2.3% | +2.3% | +0.9% | -0.3% | -0.8% | -1.4% | -0.4% | +1.6% | -4.5% | |
| – | -0.6% | +0.3% | -0.7% | -0.4% | +0.1% | -0.1% | -2.9% | -1.3% | +0.0% | +0.6% | +0.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.